investorscraft@gmail.com

Intrinsic value of Vertex Pharmaceuticals Incorporated (VRTX)

Previous Close$258.59
Intrinsic Value
Upside potential
Previous Close
$258.59

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Cash & ST Investments
Total debt
Market cap, m$
65,811

Based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %22.5NaN
Revenue, $7604NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m4822NaN
Operating income, $m2782NaN
EBITDA, $m2908NaN
Interest expense (income), $mNaN
Earnings before tax, $m2730NaN
Tax expense, $m388NaN
Net income, $m2342NaN

BALANCE SHEET

Cash and short-term investments, $m7530NaN
Total assets, $m13433NaN
Adjusted assets (=assets-cash), $m5903NaN
Average production assets, $m2756NaN
Working capital, $m7419NaN
Total debt, $m967NaN
Total liabilities, $m3333NaN
Total equity, $m10100NaN
Debt-to-equity ratio0.096NaN
Adjusted equity ratio0.449NaN

CASH FLOW

Net income, $m2342NaN
Depreciation, amort., depletion, $m126NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m2644NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-235NaN
Free cash flow, $m2879NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m7419
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount